←Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Squamous Cell Carcinoma Asia
Zuhua Lu
MD
🏢Peking University Cancer Hospital🌐China
Professor, Department of GI Oncology
42
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Zuhua Lu has contributed to the development of camrelizumab and other Chinese anti-PD-1 agents for esophageal squamous cell carcinoma. Her clinical research addresses first-line immunotherapy combinations specific to the Chinese ESCC population. She has been instrumental in Chinese ESCC treatment guideline development.
Share:
🧪Research Fields 研究领域
Esophageal squamous cell carcinoma
Camrelizumab
Anti-PD-1 therapy
Chinese ESCC trials
Biomarker research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Zuhua Lu 的研究动态
Follow Zuhua Lu's research updates
留下邮箱，当我们发布与 Zuhua Lu（Peking University Cancer Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment